DOCSLIB.ORG

State of Medicon Valley 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
State of Medicon Valley 2017 STATE OF MEDICON VALLEY 2017 An Analysis of Life Science in Greater Copenhagen PREFACE Danish-Swedish Medicon Valley continues to reinforce its position as Scandinavia’s leading life science region. The life science sector in the Greater Copenhagen region has demonstrated a strong ability to get through crises, as well as a capacity for renewal. In this year’s edition of State of Medicon Valley, we show how sector drift is also becoming discernible in the regions’ science parks, and the possibilities that materialise when biology and IT meet in new domains like e-health. The life science sector is important for the region, and for Denmark and Sweden on the whole. It generates exports, new jobs, and substantial tax revenue. MVA’s analysis shows that the tax contribution for the Danish life science sector is 15,4 billion DKK for 2015. The corresponding figure for the Swedish life science sector is 11,6 billion SEK. Despite problems with pricing pressure and increased competition in the USA, we see that Novo Nordisk is continuing to grow on its home turf as well, as are Lundbeck and Ferring. The influx of new companies at Copenhagen Bio Science Park, COBIS, is stronger than ever, and the new companies are following the new trend: they are small, virtual and technology-oriented. On the Swedish side of the Öresund Strait in Lund, Medicon Village is growing so rapidly that a new building is being constructed. Owner foundations such as Novo Nordisk Foundation, Lundbeck Foundation and LEO Foundation are demonstrating solid responsibility for the sector with large donations to life science research, as well as investments in new biotech companies. Looking at the countries comparatively, we see that Danish life science is continuing STATE OF MEDICON VALLEY 2017 to grow in terms of exports, as well as the number of employees, whilst Swedish life science exports are losing momentum after an upswing in 2015. An Analysis of Life Science in Greater Copenhagen Denmark and Sweden are currently competing with one another and a number of other countries as they vie for the appointment as the new host nation for the European Medicines Agency, EMA. Competition between the two countries instead of collaboration, Commissioned and published by: Medicon Valley Alliance. is unfortunate and can negatively impact the chances of EMA being placed in Scandi- This analysis has been prepared by Øresundsinstituttet and was navia. The situation illustrates that work still needs to be done to strengthen relations written by Jenny Andersson, Britt Andresen (chief analyst), and improve willingness to communication between Sweden and Denmark. A stronger Anna Palmehag and Johan Wessman. collaboration between the countries is absolutely vital for reinforcing the life science Project manager: Jenny Andersson. industry’s competitive power in Scandinavia in general, and in Medicon Valley specifically. Translation: Justina Bartoli. Cover photo: Novo Nordisk. State of Medicon Valley 2017 is part of an ongoing analytic collaboration between Medi- con Valley Alliance and Øresundsinstituttet that commenced last year. This annual report November 2017 is also supplemented by an interim report, where the focus is life science research at the universities and research centres in the Öresund Region/the Greater Copenhagen region. Copenhagen and Malmö 10 November 2017 Petter Hartman CEO Medicon Valley Alliance PHOTO: NOVO NORDISK NOVO PHOTO: TABLE OF CONTENTS 1. SUMMARY ..................................................................................................................... 6 2. TAX CONTRIBUTION .................................................................................................... 10 3. FACTS AND FIGURES ................................................................................................... 16 4. BIOTECH IN FOCUS ...................................................................................................... 28 5. THE BEACONS OF MEDICON VALLEY ........................................................................ 46 6. IN-HOME MEDICAL CARE ........................................................................................... 58 7. RESEARCH IN MEDICON VALLEY .............................................................................. 68 8. ANALYSIS ................................................................................................................... 80 9. APPENDIX ................................................................................................................... 90 - STATISTICS AND METHODOLOGY ................................................................................... 91 - INTERVIEW LIST............................................................................................................... 96 - LARGER MEETINGS AND CONFERENCES ..................................................................... 97 - REPORTS AND FACTS ..................................................................................................... 98 - ORGANISATIONS ............................................................................................................. 100 - REFERENCE LIST ........................................................................................................... 102 PHOTO: NOVO NORDISK NOVO PHOTO: SUMMARY 41 300 NEWS ØRESUND PHOTO: was the number of employees at life PHOTO: GENMAB PHOTO: science companies in Medicon Valley in 2015. That is equal to 58% of the total number of employees in the life science industry in Denmark and Sweden. The number of employees has increased by 3.6% under 2015. It’s been a good year for Copenhagen Bio Science Park, COBIS. Forty new companies have moved in, 126 200 employees in and at the end of October the tenant Orphazyme THE SUCCESSES CONTINUE made it known that it had sent an intention to float the health care sector announcement to inform that they plan to offer IN MEDICON VALLEY shares on Nasdaq Copenhagen later this year. The health care sector in the Greater Copenhagen Region employs 126 200, It can be hard to adjust to a lower speed when you’ve been some 85 300 of whom are in Eastern going fast. In its strong years, the life science industry in Denmark. That means that close to the Danish-Swedish Medicon Valley counted new jobs in the 167 500 people in the region work thousands. Now that the sector giant Novo Nordisk has had within life science and health care. In 6.3% problems in the USA and the biotech sector has matured, addition to those are researchers at Danish life science exports continued their the new jobs are in the hundreds. The important thing is that the region’s universities. growth trend through 2016 with a growth new jobs – and new companies – are still being created. Bio- rate of 6.3%, while Swedish life science tech companies are in the midst of a new boom, but this time exports dropped 2.7%. it’s all about virtual companies with few employees. The science park COBIS in Copenhagen has had a record number of new companies as tenants, but they are small in terms of – Biotech is closely associated with risks. Since the number of employees. The same goes for Medicon Villa- the turn of the millennium, anything risky has had ge in Lund, which can boast 19 listed companies. a hard time on the stock market. Slowly however, The interest in the life science sector is greater than it has PHOTO: NASDAQ COPENHAGEN NASDAQ PHOTO: we have been able to see how biotech companies been for a long time. That is apparent in a variety of ways. that were listed in Denmark around the start of At Copenhagen Bio Science Park, COBIS, the influx of new the millennium, such as Bavarian Nordic, No- companies is record-high, says CEO Morten Mølgaard Jensen. vozymes and Genmab, have done increasingly In the past year, there have been 40 new companies. But they better, says Carsten Borring, Head of Listing and are small, virtual companies, and the majority of them are not Capital Markets at Nasdaq Copenhagen. strictly biotech companies; often, they have more of a technolo- gy company character. Sector drift is increasingly noticeable. Of the companies at COBIS, the one that has attracted 15,4 bil. DKK the most attention is Orphazyme, since it announced its IPO The tax contribution for the Danish plans and a planned new share issuance of 600 million DKK in life science sector is 15,4 billion GENMAB PHOTO: October. In Lund, Medicon Village can count 19 listed compa- +410% nies on its fifth anniversary. In 2016, 15 companies at Medicon DKK in 2015. Village brought in a total of one billion SEK in new issues. The interest in investing in stock is strong among private citizens in Sweden, and there are many business angels. As a result, 11,6 bil. SEK Genmab’s share price many Danish companies are looking to the north and listing The tax contribution for the Swedish development in the their shares on Nasdaq or Aktietorget in Stockholm. life science sector is 11,6 billion past three years SEK in 2015. STATE OF MEDICON VALLEY • November 2017 7 SUMMARY SUMMARY The Swedish interest in the stock market has a and one-third in Sweden. The Novo Nordisk Founda- in Copenhagen. With regard to EMA, Sweden the dominant life science region in Scandinavia. long history. A favourable savings method in terms tion is a very important player in the region. The foun- chose to run a campaign of its own in competition The Danish life science sector’s leading position of tax called the Allemansfond (every-man’s fund) dation is a main shareholder in the successful Danish with the Danish
Load more

Recommended publications
  • ESCO-Contracting in Danish Municipalities
    Energies 2013, 6, 2407-2427; doi:10.3390/en6052407 OPEN ACCESS energies ISSN 1996-1073 www.mdpi.com/journal/energies Article Greening Public Buildings: ESCO-Contracting in Danish Municipalities Jesper Ole Jensen 1,*, Susanne Balslev Nielsen 2 and Jesper Rohr Hansen 1 1 Department of Town, Housing and Property, Danish Building Research Institute, A.C.Meyers Vænge 15, Copenhagen DK-2450, Denmark; E-Mail: [email protected] 2 Department of Management Engineering, Technical University of Denmark, Bygning 424, Kongens Lyngby DK-2800, Denmark; E-Mail: [email protected] (S.B.N.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +45-9940-2358. Received: 27 February 2013; in revised form: 11 April 2013 / Accepted: 24 April 2013 / Published: 6 May 2013 Abstract: This paper presents current research on Danish municipalities’ use of Energy Service Companies (ESCO) as a way to improve the standard of public buildings and to increase energy efficiency. In recent years more and more municipalities have used ESCO-contracts to retrofit existing public buildings, and to make them more energy efficient. At the moment 30 municipalities (of the 98 municipalities in Denmark) are involved in, or preparing, ESCO contracts. Nevertheless, ESCO-contracting still faces many challenges on the Danish market, as there is a widespread skepticism towards the concept amongst many stakeholders. The purpose of this paper is to discuss the various experience gained so far by municipalities use of ESCO-contracting, the different approached to ESCO-contracting being used in practice, as well as the different viewpoints drivers and barriers behind the development.
    [Show full text]
  • Conte Annual Report 2000 / 2001
    Coloplast’s Mission Contents Throughout the world we wish to be perceived as depend- Coloplast in brief 2 able providers of consumable products and services. 5 years’ key figures and ratios 3 Our customers are health care professionals and users. Our primary concern is to improve the quality of life of Board and Group Management 4 individuals suffering from a disabling condition. Management report 5 We respond quickly to market needs to ensure the highest level of customer satisfaction. We strive to offer Financial review 11 preferred product ranges based on innovation, advanced technology and cost-effectiveness. Risk factors 15 Accounting policies 17 All employees must be recognised for their empathy with user needs and dependability in business relations. Profit and loss account 19 It is our ambition to attract and retain the best human Balance sheet 20 resources. Consolidated cash flow statement 22 As individuals and as an organisation we will act respon- Auditors’ report and approvals 23 sibly and be socially and environmentally conscious. Notes 24 We strive to be the best within our businesses, thereby achieving growth and value for the company, the em ploy- ees and shareholders. Stakeholder reporting Annual Report 2000 / 2001 – value creation and knowledge management 32 Customers 33 Employees 38 Society 41 Shareholders 43 Indicators for value drivers and value propositions 48 Artist of the year 50 Group addresses Executives Coloplast Mission Coloplast A/S Coloplast, Conveen, Comfeel, Holtedam 1 Amoena, Sween, Compeed, DK-3050 Humlebæk Assura, Easiflex, EasiCath, Coloplast’s Annual Report for 2000/01 has its own Tel. + 45 49 11 11 11 SpeediCath, Biatain, Contreet, microsite on our corporate website at the address: Fax + 45 49 11 15 55 and Prema are registered trade- E-mail: [email protected] marks of the Coloplast Group.
    [Show full text]
  • Stakeholder Involvement Work Package 8
    Stakeholder Involvement Work Package 8 European Union European Regional Development Fund Kop 2 Fife Coast and Countryside Trust was responsible for the coordination of Work Package 8: “Stakeholder Involvement”. This report was prepared by Julian T. Inglis, Fulcrum Environmental Management, on behalf of the Trust. The thoughts and opinions expressed in this report are those of the author and do not necessarily reflect the views of the Trust or other partners in the SUSCOD project. The author is solely responsible for the accuracy of the information contained in the report. Please send your comments to [email protected] Table of Contents Summary 6 Section 1: Introduction to stakeholder involvement in the SUSCOD project .........................................8 Section 2: Process for developing the final report on stakeholder involvement .............................. 11 Section 3: A typology of the main categories of stakeholder involvement .......................................... 14 a. Partnerships ............................................................................................................................................................. 15 (i) Coastal Partnerships ............................................................................................................................................... 15 Coastal partnerships in Scotland ............................................................................................................... 16 Coastal Partnerships and emerging marine planning partnerships
    [Show full text]
  • Life After Shrinkage
    LIFE AFTER SHRINKAGE CASE STUDIES: LOLLAND AND BORNHOLM José Antonio Dominguez Alcaide MSc. Land Management 4th Semester February – June 2016 Study program and semester: MSc. Land Management – 4th semester Aalborg University Copenhagen Project title: Life after shrinkage – Case studies: Lolland and Bornholm A.C. Meyers Vænge 15 2450 Copenhagen SV Project period: February – June 2016 Secretary: Trine Kort Lauridsen Tel: 9940 3044 Author: E-mail: [email protected] Abstract: Shrinkage phenomenon, its dynamics and strategies to José Antonio Dominguez Alcaide counter the decline performed by diverse stakeholders, Study nº: 20142192 are investigated in order to define the dimensions and the scope carried out in the places where this negative transformation is undergoing. The complexity of this process and the different types of decline entail a study in Supervisor: Daniel Galland different levels from the European to national (Denmark) and finally to a local level. Thus, two Danish municipalities Pages 122 (Lolland and Bornholm) are chosen as representatives to Appendix 6 contextualize this inquiry and consequently, achieve more accurate data to understand the causes and consequences of the decline as well as their local strategies to survive to this changes. 2 Preface This Master thesis called “Life after shrinkage - Case studies: Lolland and Bornholm” is conducted in the 4th semester of the study program Land Management at the department of Architecture, Design and Planning (Aalborg University) in Copenhagen in the period from February to June 2016. The style of references used in this thesis will be stated according to the Chicago Reference System. The references are represented through the last name of the author and the year of publication and if there are more than one author, the quote will have et al.
    [Show full text]
  • Aktienyt Novozymes
    Aktienyt Novozymes Hold Udfordrende markeder dæmper salgsvæksten Uændret Hold-anbefaling siden 20/04/2016 Vi fastholder vores Hold-anbefaling på Novozymes Dagens regnskab er lidt svagere, end vi havde ventet. Hård priskonkurrence i ’Bioenergi’ og økonomisk Analysedato: 10/08/2016 pressede kunder i ’Landbrug og Foder’ dæmper Novozymes’ salgsvækst. Pris- fastsættelsen af Novozymes-aktien afspejler efter vores vurdering Novozymes’ Aktuel kurs kl. 12:11: kortsigtede forretningsmuligheder. 295,00 DKK Salgsvæksten skuffer i årets 2. kvartal Omsætningen på 3.429 mio. kr. i 2. kvartal 2016 er 3,3% dårligere end vores estimat (-3,5% i Begivenhed: forhold til markedsforventningen). Resultatet af primær drift på 961 mio. kr. i 2. kvartal 2016 er 2,9% under vores estimat (-2,6% i forhold til markedsforventningen). I forhold til vores for- 2. kvartalsregnskab ventning er det specielt salget i divisionerne ’Bioenergi’ og ’Landbrug og Foder’, der viser en svagere end ventet udvikling i 2. kvartal. Novozymes justerer salgsprognosen for 2016 i lokal Seneste analyse: valuta. Selskabet venter nu en salgsvækst i lokal valuta på 2-4% i 2016 mod tidligere 3-5%. 05/08/16 – Vækst i ’Vaskemid- Novozymes forventer, at salgsvæksten i danske kroner forbliver uændret på 1-3% i 2016. ler’ – Tilbagegang i ’Bioenergi’ Salgsvæksten i ’Vaskemidler’ overgår vores forventning Den organiske salgsvækst i divisionen ’Vaskemidler’ på 4% i 2. kvartal er lidt bedre end vo- res estimat på 3%. Vi hæfter hos ved, at salget vokser i Asien drevet af øget penetration af Kalender: enzymer i flydende vaskemidler. Yderligere noterer vi os, at den positive salgsudvikling er 26/10/16 – 3.
    [Show full text]
  • Genmab Announces Data to Be Presented at 2017 ASCO Annual Meeting
    Genmab Announces Data to be Presented at 2017 ASCO Annual Meeting Media Release 8 abstracts on Genmab programs scheduled for presentation at ASCO Two daratumumab oral presentations and five daratumumab poster presentations Copenhagen, Denmark; April 20, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that seven daratumumab abstracts have been accepted for presentation at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 2 – 6. These abstracts, submitted by our collaboration partner, Janssen Biotech, Inc., include updates for the POLLUX and CASTOR trials, and the first data for a Phase I study evaluating daratumumab with carfilzomib, lenalidomide and dexamethasone in front line multiple myeloma patients, which will be presented in an oral presentation. In addition, descriptions of the Phase Ib/II study of daratumumab plus atezolizumab in non-small cell lung cancer and of our Phase I/II study with HuMax-AXL-ADC are scheduled for poster presentations at the meeting. The titles of the abstracts are currently available on the ASCO website with the full abstracts scheduled to be published on May 17, 2017. “We are very pleased that, once again, a number of abstracts based on exciting work with Genmab’s innovative therapeutic antibody products have been accepted for presentation at the prestigious ASCO conference,” said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab. List of abstracts: Daratumumab: Efficacy Of Daratumumab In Combination with Lenalidomide Plus Dexamethasone (DRd) or
    [Show full text]
  • Genmab's 2020 Capital Markets
    WELCOME Genmab’s 2020 Capital Markets Day November 13, 2020 Webcast Live from Utrecht and Princeton Forward Looking Statement This presentation contains forward looking statements. The words “believe”, “expect”, “anticipate”, “intend” and “plan” and similar expressions identify forward looking statements. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding our financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to our products), are forward looking statements. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Such forward looking statements are based on numerous assumptions regarding our present and future business strategies and the environment in which we will operate in the future. The important factors that could cause our actual results, performance or achievements to differ materially from those in the forward looking statements include, among others, risks associated with product discovery and development, uncertainties related to the outcome of clinical trials, slower than expected rates of patient recruitment, unforeseen safety issues resulting from the administration of our products in patients, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors.
    [Show full text]
  • ERSA 2010 Sanchez Et Al Medicon Valley
    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Carreira, Maria Del Carmen Sanchez; Deza, Xavier Vence; Marzábal, Óscar Rodil Conference Paper Strategic innovation policies and the emergence of new clusters: the comparative experience of the binational Medicon Valley 50th Congress of the European Regional Science Association: "Sustainable Regional Growth and Development in the Creative Knowledge Economy", 19-23 August 2010, Jönköping, Sweden Provided in Cooperation with: European Regional Science Association (ERSA) Suggested Citation: Carreira, Maria Del Carmen Sanchez; Deza, Xavier Vence; Marzábal, Óscar Rodil (2010) : Strategic innovation policies and the emergence of new clusters: the comparative experience of the binational Medicon Valley, 50th Congress of the European Regional Science Association: "Sustainable Regional Growth and Development in the Creative Knowledge Economy", 19-23 August 2010, Jönköping, Sweden, European Regional Science Association (ERSA), Louvain-la-Neuve This Version is available at: http://hdl.handle.net/10419/119144 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich
    [Show full text]
  • State of Medicon Valley 2018
    A COMPARISON OF SCIENTIFIC PUBLICATIONS IN 10 EUROPEAN LIFE SCIENCE CLUSTERS STOCKHOLM-UPPSALA SCOTLAND MEDICON VALLEY NETHERLANDS LONDON-CAMBRIDGE-OXFORD FLANDERS ÎLE DE FRANCE BIOVALLEY MUNICH ZURICH STATE OF MEDICON VALLEY 2018 An Analysis of Life Science in Greater Copenhagen PREFACE Medicon Valley is in a period of transition. The life science sector has been the region’s growth motor, even through the darkest years of the economic crisis. But now is no time to rest on laurels. The sector is facing new research breakthroughs in everything from personalised medicine to biopharmaceuticals and gene therapy. The dividing lines to other sectors are being dissolved with new digital solutions and arti- ficial intelligence that in part facilitate diagnostics and in part give patients increased control over their care. One of the most important foundations for the creation of a competitive life science cluster is the access to – and the emergence of – internationally leading university environments and research institutions. For this reason, we have commissioned a unique comparison of Europe’s ten most influential life science clusters, based on scientific publication volume in the life sciences, from the Dutch research institute CWTS at Leiden University. We’re happy to report that the percentual increase in scientific publications in the life sciences is greater in Medicon Valley than in any other cluster in Europe’s other Top Ten. Calculated according to the number of publications, the region’s placement is firmly in the middle of the list, at the top of which is the life science cluster in Lon- STATE OF MEDICON VALLEY 2018 don-Cambridge-Oxford.
    [Show full text]
  • Annual Report 2019
    Hovedstadens I Letbane Hovedstadens S Letbane I/S Annual Report Annual Report Hovedstadens Letbane I/S Metrovej DK- Copenhagen S CVR number: T + E [email protected] Read more about the Greater Copenhagen Light Rail at dinletbane.dk Cover visualisation: Gottlieb Paludan Architects Layout, e-Types Printing, GraphicUnit ApS ISBN number: ---- EMÆR AN KE V T S Tryksag 5041 0473 Annual Report 2019 Contents Foreword 05 2019 In Brief 06 Directors’ Report 08 Results and Expectations 08 Status of the Greater Copenhagen Light Rail 16 Design 22 Communication 23 Safety on the Right Track 25 Corporate Management 26 Compliance and CSR Report 27 Annual Accounts 35 Accounting Policies 36 Accounts 39 Management Endorsement 59 Independent Auditors’ Report 60 Appendix to the Directors’ Report 65 Long-Term Budget 66 3 The Light Rail will run under the viaduct at Buddingevej before continuing up to Lyngby Station. Visualisation: Gottlieb Paludan Architects Annual Report 2019 Foreword The Greater Copenhagen Light Rail will be 2019 was the year in which the Light Rail In May, the design of the coming Light Rail part of the public transport network that construction activities got underway and trains was decided on. The trains will be will enable residents, commuters and busi- the project became visible in several places green and will thereby have their own iden- nesspeople to get around in an easy, fast and along Ring 3. The major preparatory works tity in relation to the other modes of trans- more environmentally friendly way. When it at Lyngby Station, Buddinge Station and the port in the Greater Copenhagen area, while goes into operation, the Light Rail will run Control and Maintenance Centre in Glostrup also making it easy to spot the Light Rail in on electricity, which is one of the most en- picked up speed and utility line owners began the cityscape.
    [Show full text]
  • View of Where There Are Fillings Heights As Both Maps Are Based on the Field Survey and Fill Thickness
    The Journal of Transdisciplinary Environmental Studies vol. 12, no. 2, 2013 Public Archives and other Sources for Surveying of Dumpsites and Polluting Enterprises before 1950 Anne-Sofie Fleischer Michaelsen,Department of Environmental, Social and Spatial Change, Roskilde University, Denmark E-mail: [email protected] Abstract: In Denmark, the local environmental authorities have had an obligation to survey areas for soil contamination since the early 1980s. Through the years, detecting and locating old dumpsites and gathering historical information on them have been very dependent on old aerial photographs. As a result, the environmental authorities only have little knowledge of dumpsites operating before the mid-1950s. This study describes the utility of various historical sources for surveying of old dumpsites in the former Ballerup-Maaløv Municipality near Copenhagen. The minute books of the Council and the Health Commission in the municipality were used. In order to locate two dumpsites mentioned in the minute books and gather information on them, the fol- lowing additional sources were used: Old census papers, index cards from tax assessments of real property, income tax returns, writings from local history societies on the former villages, recorded memories told by senior citizens and jubilee publications from homeowners’ associations together with old cadastral maps, old topographical maps, and old aerial photographs plus a comparison of terrain heights in a topographical military map from 1900 and the Danish Elevation Model from 2005-2007. The minute books of the Council and the Health Commission contain information on 31 dumpsites and 15 possible dumpsites of very different characteristics. Only a few of the dumpsites were already known by the local environmental authorities.
    [Show full text]
  • Villum Fonden
    VILLUM FONDEN Technical and Scientific Research Project title Organisation Department Applicant Amount Integrated Molecular Plasmon Upconverter for Lowcost, Scalable, and Efficient Organic Photovoltaics (IMPULSE–OPV) University of Southern Denmark The Mads Clausen Institute Jonas Sandby Lissau kr. 1.751.450 Quantum Plasmonics: The quantum realm of metal nanostructures and enhanced lightmatter interactions University of Southern Denmark The Mads Clausen Institute N. Asger Mortensen kr. 39.898.404 Endowment for Niels Bohr International Academy University of Copenhagen Niels Bohr International Academy Poul Henrik Damgaard kr. 20.000.000 Unraveling the complex and prebiotic chemistry of starforming regions University of Copenhagen Niels Bohr Institute Lars E. Kristensen kr. 9.368.760 STING: Studying Transients In the Nuclei of Galaxies University of Copenhagen Niels Bohr Institute Georgios Leloudas kr. 9.906.646 Deciphering Cosmic Neutrinos with MultiMessenger Astronomy University of Copenhagen Niels Bohr Institute Markus Ahlers kr. 7.350.000 Superradiant atomic clock with continuous interrogation University of Copenhagen Niels Bohr Institute Jan W. Thomsen kr. 1.684.029 Physics of the unexpected: Understanding tipping points in natural systems University of Copenhagen Niels Bohr Institute Peter Ditlevsen kr. 1.558.019 Persistent homology as a new tool to understand structural phase transitions University of Copenhagen Niels Bohr Institute Kell Mortensen kr. 1.947.923 Explosive origin of cosmic elements University of Copenhagen Niels Bohr Institute Jens Hjorth kr. 39.999.798 IceFlow University of Copenhagen Niels Bohr Institute Dorthe DahlJensen kr. 39.336.610 Pushing exploration of Human Evolution “Backward”, by Palaeoproteomics University of Copenhagen Natural History Museum of Denmark Enrico Cappellini kr.
    [Show full text]